mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.007 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.008 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.008 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.008 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.008 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.009 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.01 |